HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

ANC 1

structure in first source
Also Known As:
7,8-Dicarbaundecaborate(1-), 7-(3-aminopropyl)undecahydro-, hydrogen; 7-(3-aminopropyl)-7,8-dicarba-nido-undecarborate(-1); ANC-1
Networked: 13 relevant articles (2 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Langevitz, P: 1 article (02/2015)
2. Shoenfeld, Y: 1 article (02/2015)
3. Shovman, O: 1 article (02/2015)
4. Nottage, Kerri: 1 article (12/2014)
5. Aygun, Banu: 1 article (12/2014)
6. Wang, Winfred C: 1 article (12/2014)
7. Thornburg, Courtney: 1 article (12/2014)
8. Ware, Russell E: 1 article (12/2014)
9. Hankins, Jane S: 1 article (12/2014)
10. Smeltzer, Matthew P: 1 article (12/2014)

Related Diseases

1. Neutropenia
04/01/2013 - "Incremental cost-effectiveness ratios (ICER) were calculated for the major endpoints of the trial; i.e., duration of febrile neutropenia (absolute neutrophil count [ANC] <0.5 × 10(9)/L and temperature ≥38 °C), duration of neutropenia (ANC <1.0 × 10(9)/L and ANC <0.5 × 10(9)/L), duration of thrombopenia (platelets <50 × 10(9)/L and <20 × 10(9)/L), and days with a temperature ≥38 °C). "
12/01/2014 - "The median maximum tolerated dose of hydroxyurea has decreased from 30 to 26 mg/kg/day (range 19.5-31.2); neutropenia [absolute neutrophil count (ANC)<1.0×10⁹/L] prompting temporary drug discontinuation occurred a total of 10 times in 4 subjects and there was no severe neutropenia (ANC<0.5×10⁹/L). "
07/01/1993 - "42 patients 1-22 years of age suffering from solid tumors, hematological and oncological diseases, with clinical signs of infection, increased serum CRP (> 1 mg/dl) and/or fever above 38.5 degrees C and neutropenia (WBC count and/or ANC < 1 x 10(9)/l) were included in this outpatient based study. "
01/01/2013 - "Subjects were classified into subgroups based on whether or not they were hospitalized for FN per the presumptive "gold standard" (ANC <1.0×10(9)/L, and body temperature ≥38.3°C or receipt of antibiotics) and claims-based definition (diagnosis codes for neutropenia, fever, and/or infection). "
06/30/1998 - "Reasons other than neutropenia for discontinuing use of deferiprone included nausea (4), voluntary withdrawal (3), high ALT (2), platelet count < 100,000/mm3 (2), low but unconfirmed ANC (1), protocol violation (1) fatigue (1), and depression (1). "
2. Infection
3. Neoplasms (Cancer)
4. Fever (Fevers)
5. Leukemia

Related Drugs and Biologics

1. Anti-Bacterial Agents (Antibiotics)
2. Filgrastim (Neupogen)
3. Granulocyte Colony-Stimulating Factor (G-CSF)
4. Sulfasalazine (Azulfidine)
5. Phosphorylcholine (Phosphocholine)
6. Hydroxyurea (Hydrea)
7. pegfilgrastim (Neulasta)
8. TNFR-Fc fusion protein (etanercept)
9. 1- (9- o- carboranyl)nonyl- 2- methyl- glycero- 3- phosphocholine
10. DAC 1

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Platelet Transfusion (Blood Platelet Transfusions)
3. Boron Neutron Capture Therapy